Marek Witold Radomski
#130,164
Most Influential Person Now
Marek Witold Radomski's AcademicInfluence.com Rankings
Marek Witold Radomskimedical Degrees
Medical
#2156
World Rank
#2559
Historical Rank
Pharmacology
#225
World Rank
#265
Historical Rank
Download Badge
Medical
Why Is Marek Witold Radomski Influential?
(Suggest an Edit or Addition)Marek Witold Radomski's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM (1987) (1494)
- An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. (1990) (1226)
- The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide (1987) (1177)
- Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. (1990) (1128)
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets (1987) (834)
- The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. (1987) (764)
- Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. (1988) (679)
- Nanoparticles: pharmacological and toxicological significance (2007) (634)
- Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. (2013) (625)
- Nanoparticle‐induced platelet aggregation and vascular thrombosis (2005) (603)
- cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. (1996) (479)
- Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. (1990) (458)
- Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. (2000) (410)
- Magnetic Nanoparticles in Cancer Theranostics (2015) (368)
- Nitric oxide synthase activities in human myocardium (1993) (366)
- Release of gelatinase A during platelet activation mediates aggregation (1997) (366)
- Paradoxical fate and biological action of peroxynitrite on human platelets. (1994) (363)
- Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. (1999) (360)
- S‐nitroso‐glutathione inhibits platelet activation in vitro and in vivo (1992) (334)
- Characterization of the l‐arginine: nitric oxide pathway in human platelets (1990) (329)
- Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation (2004) (303)
- Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. (1994) (301)
- Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. (1993) (233)
- Regulation of Vascular Homeostasis by Nitric Oxide (1993) (229)
- Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty (1994) (219)
- An improved method for washing of human platelets with prostacyclin. (1983) (209)
- Long-Term Doxycycline Is More Effective Than Atenolol to Prevent Thoracic Aortic Aneurysm in Marfan Syndrome Through the Inhibition of Matrix Metalloproteinase-2 and -9 (2008) (207)
- Role of Matrix Metalloproteinases in Intestinal Inflammation (2006) (202)
- Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. (1991) (200)
- miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity (2015) (199)
- Direct electrochemical measurement of nitric oxide released from human platelets. (1993) (196)
- The formation of nitric oxide donors from peroxynitrite (1995) (195)
- Differential Regulation of Platelet Aggregation by Matrix Metalloproteinases-9 and -2 (1999) (194)
- Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. (2013) (192)
- Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder (2004) (184)
- Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. (1994) (176)
- Distribution of nitric oxide synthase in normal and cirrhotic human liver (2002) (172)
- Direct measurement of nitric oxide in human beings (1995) (166)
- Extracorporeal life support (2010) (166)
- Vascular Matrix Metalloproteinase-2–Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction (2000) (165)
- The biological and pharmacological role of nitric oxide in platelet function. (1993) (153)
- Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. (1991) (150)
- Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. (1994) (136)
- Nitric oxide--biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. (1995) (134)
- The Nitric Oxide-Endothelin-1 Connection (2004) (132)
- Role of metalloproteinases in platelet function. (2008) (126)
- Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. (2001) (119)
- The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates (2000) (116)
- Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects (2011) (114)
- The use of prostacyclin in the separation from plasma and washing of human platelets. (1982) (113)
- Synthesis of Nitric Oxide by the Haemocytes of the American Horseshoe Crab (Limulus polyphemus) (1991) (112)
- Approaches to the safety assessment of engineered nanomaterials (ENM) in food. (2012) (107)
- Localization and Translocation of MMP-2 during Aggregation of Human Platelets (1998) (106)
- Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: protective effects of fisetin. (2012) (105)
- Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. (1995) (103)
- Membrane type‐1 matrix metalloproteinase stimulates tumour cell‐induced platelet aggregation: role of receptor glycoproteins (2004) (102)
- Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling. (2011) (99)
- Metal nanoparticles in dermatology and cosmetology: Interactions with human skin cells. (2017) (99)
- The Terminal Portion of the T Wave: A New Electrocardiographic Marker of Risk of Ventricular Arrhythmias (2000) (97)
- Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients (2006) (94)
- Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice. (2006) (93)
- Selectins--potential pharmacological targets? (2006) (92)
- Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis. (2003) (89)
- The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia‐induced lung injury in newborn rats (1998) (89)
- Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis (2012) (88)
- Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactions. (2014) (85)
- Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. (1998) (84)
- The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. (1998) (84)
- Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets (2002) (82)
- Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway. (2014) (80)
- Mechanisms of action of proteinase‐activated receptor agonists on human platelets (2002) (77)
- Titanium dioxide nanoparticles enhance production of superoxide anion and alter the antioxidant system in human osteoblast cells (2015) (76)
- Nitric oxide activates chloride currents in human lung epithelial cells. (1997) (70)
- Matrix metalloproteinase‐9 modulates intestinal injury in rats with transmural colitis (2006) (69)
- Nitric Oxide and Cyclic GMP Increase the Expression of Matrix Metalloproteinase-9 in Vascular Smooth Muscle (2003) (66)
- Platelet Aggregation-Induced by Caco-2 Cells: Regulation by Matrix Metalloproteinase-2 and Adenosine Diphosphate (2006) (66)
- Generation and role of angiostatin in human platelets. (2003) (63)
- Prostacyclin prolongs viability of washed human platelets. (1982) (61)
- Nitric oxide and platelet function: implications for neonatology. (1997) (59)
- Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase (1993) (59)
- Nitric oxide: biological mediator, modulator and effector. (1995) (59)
- Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats. (2012) (59)
- Pharmacological and toxicological effects of co-exposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride (2014) (59)
- Nonremodeling properties of matrix metalloproteinases: the platelet connection. (2002) (58)
- Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates (1998) (58)
- The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges. (2016) (58)
- Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases (2004) (56)
- Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. (2001) (56)
- Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK (2008) (55)
- Fisetin prevents fluoride- and dexamethasone-induced oxidative damage in osteoblast and hippocampal cells. (2012) (55)
- The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation (2012) (53)
- Pegylation increases platelet biocompatibility of gold nanoparticles. (2014) (53)
- Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. (1992) (52)
- Comparative pharmacology of analogues of S‐nitroso‐N‐acetyl‐dl‐penicillamine on human platelets (1994) (52)
- CuO nanoparticles induce apoptosis by impairing the antioxidant defense and detoxification systems in the mouse hippocampal HT22 cell line: protective effect of crocetin. (2015) (51)
- The Role of Mucin in the Toxicological Impact of Polystyrene Nanoparticles (2018) (50)
- Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation (2017) (49)
- Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. (2000) (48)
- Sepsis-associated thrombocytopenia. (2016) (48)
- Protein Kinase Cδ Mediates Platelet-Induced Breast Cancer Cell Invasion (2006) (47)
- Differential release of matrix metalloproteinase‐9 and nitric oxide following infusion of endotoxin to human volunteers (2003) (47)
- N-substituted homopiperazine barbiturates as gelatinase inhibitors. (2011) (45)
- Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance. (1998) (45)
- Systemic effects of S-nitroso-glutathione in the human following intravenous infusion. (1995) (44)
- Molecular Mechanism of Silver Nanoparticles-Induced Human Osteoblast Cell Death: Protective Effect of Inducible Nitric Oxide Synthase Inhibitor (2016) (43)
- Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles. (2009) (41)
- Polarized Release of Matrix Metalloproteinase-2 and -9 from Cultured Human Placental Syncytiotrophoblasts1 (2000) (41)
- Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study. (2005) (41)
- Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis (2006) (41)
- Role of von Willebrand factor in tumour cell‐induced platelet aggregation: differential regulation by NO and prostacyclin (2001) (40)
- Nitric Oxide, Platelet Function, Myocardial Infarction and Reperfusion Therapies (2004) (39)
- Rapid Release of Matrix Metalloproteinase (MMP)-2 by Thrombin in the Rat Aorta: Modulation by Protein Tyrosine Kinase/Phosphatase (1999) (37)
- Pharmacological characteristics of solid‐phase von Willebrand factor in human platelets (2001) (37)
- Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells. (1999) (36)
- Megakaryocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase. (1995) (36)
- Therapeutic effect of phenantroline in two rat models of inflammatory bowel disease. (2001) (35)
- Platelets, photosensitizers, and PDT. (2013) (34)
- Nitric oxide in the clinical arena. (1994) (33)
- Isolation and washing of human platelets with nitric oxide. (1988) (32)
- The Problems and the Promise of Prostaglandin Influences in Atherogenesis (1985) (32)
- Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. (2001) (31)
- Nitric oxide and the pathogenesis of heart muscle disease (1995) (30)
- Biodistribution and pharmacokinetic studies of SPION using particle electron paramagnetic resonance, MRI and ICP-MS. (2015) (30)
- Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study. (2003) (29)
- The Transcription Factor Wilms Tumor 1 Regulates Matrix Metalloproteinase-9 through a Nitric Oxide-Mediated Pathway (2007) (28)
- Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups. (2009) (27)
- Blood biocompatibility of surface-bound multi-walled carbon nanotubes. (2015) (27)
- Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin‐resistant, obese JCR:LA‐cp rats (1998) (27)
- [9] Nitric oxide in platelets (1996) (27)
- Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion. (2012) (27)
- Pharmacokinetics and bio‐distribution of novel super paramagnetic iron oxide nanoparticles (SPIONs) in the anaesthetized pig (2016) (26)
- Analysis of platelet function: role of microfluidics and nanodevices. (2011) (25)
- CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility (2015) (25)
- Protein kinase C delta mediates platelet-induced breast cancer cell invasion. (2006) (24)
- Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. (2003) (24)
- Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions. (2015) (23)
- Differential inhibition of tumour cell‐induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin (2012) (23)
- Induction of nitric oxide release by interferon-gamma inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. (1994) (22)
- Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by s-nitrosoglutathione. (1999) (21)
- An ultrastructural study of stored human platelets after washing using prostacyclin (1985) (20)
- Effects of functionalized silver nanoparticles on aggregation of human blood platelets (2019) (20)
- New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and Autophagy in Human Pancreatic Ductal Adenocarcinoma Cell Lines (2019) (19)
- Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry (2015) (19)
- Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. A preliminary study. (2003) (18)
- The role of nitric oxide in the regulation of ion channels in airway epithelium: Implications for diseases of the lung (2000) (18)
- Differential effects of intrathecally and intracerebroventricularly administered nitric oxide donors on noxious mechanical and thermal stimulation. (1998) (18)
- Angiotensin-induced release of prostacyclin (PGI2) into circulation of anaesthetized cats. (1979) (18)
- A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery. (2009) (18)
- Nitric oxide, platelet function, myocardial infarction and reperfusion therapies. (2003) (17)
- Nitric oxide in platelets. (1996) (16)
- Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin. (1994) (16)
- An abnormality of arachidonic acid metabolism is not a generalized phenomenon in patients with aspirin-induced asthma. (1988) (16)
- Intestinal microbiota transplant – current state of knowledge (2016) (15)
- Cardioprotective effect of MMP‐2‐inhibitor‐NO‐donor hybrid against ischaemia/reperfusion injury (2019) (15)
- Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels. (2003) (15)
- Effects of LY117018 and the Estrogen Analogue, 17α-Ethinylestradiol, on Vascular Reactivity, Platelet Aggregation, and Lipid Metabolism in the Insulin-Resistant JCR:LA-cp Male Rat: Role of Nitric Oxide (2001) (15)
- MMP inhibition by barbiturate homodimers. (2013) (14)
- MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study (2017) (14)
- Pharmacologic Protein Kinase Cα Inhibition Uncouples Human Platelet-Stimulated Angiogenesis from Collagen-Induced Aggregation (2013) (14)
- Gender differences and in-hospital mortality in patients undergoing percutaneous coronary interventions. (2008) (12)
- Role of matrix metalloproteinases 2 and 9, toll-like receptor 4 and platelet-leukocyte aggregate formation in sepsis-associated thrombocytopenia (2018) (12)
- Platelet Dysfunction in Asphyxiated Newborn Piglets Resuscitated with 21% and 100% Oxygen (2006) (12)
- Prostacyclin and the mechanism of action of defibrotide. (1989) (11)
- Matrix metalloproteinases in platelet function: coming of age (2008) (11)
- Characterisation of the R3/1 cell line as an alveolar epithelial cell model for drug disposition studies. (2009) (10)
- Role of inducible nitric-oxide synthase in regulation of whole-cell current in lung epithelial cells. (2000) (10)
- Extracorporeat life support (2010) (10)
- One-year outcomes of left main coronary artery stenting in patients with cardiogenic shock. (2007) (10)
- Conversion of exogenous arachidonic acid to prostaglandins in the pulmonary circulation in vivo. A human and animal study. (1981) (9)
- Predicted and observed in-hospital mortality after left main coronary artery stenting in 204 patients. (2008) (9)
- The ion selective function of the epithelium of the membranous canal walls. (1968) (9)
- Usefulness of optical coherence tomography in the assessment of atherosclerotic culprit lesions in acute coronary syndromes. Comparison with intravascular ultrasound and virtual histology. (2008) (9)
- Inhibition of human platelet aggregation by vitamin K. (1985) (8)
- Nitric oxide mediates the vascular actions of cytokines in septic shock (1992) (8)
- Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits. (2003) (8)
- Regulation of Platelet Function (2000) (7)
- Mechanisms of aggregation inhibition by aspirin and nitrate‐aspirin prodrugs in human platelets (2012) (7)
- Disaggregatory action of phosphodiesterase inhibitors. (1981) (7)
- The biological role of thromboxane A2 in the process of hemostasis and thrombosis; pharmacology and perspectives of therapeutical use of thromboxane synthetase inhibitors and receptor PGH2/TXA2 antagonists. (1985) (7)
- Biological Significance of Nitric Oxide (1995) (6)
- Regulation of Platelet Function by Nitric Oxide and Other Nitrogen-and Oxygen-Derived Reactive Species (1997) (6)
- Salicylates and 12-lipoxygenase activity in human washed platelets. (1986) (6)
- Percutaneous coronary angioplasty in elderly patients: Assessment of in-hospital outcomes. (2007) (6)
- Differential expression of matrix metalloproteinases and the tissue inhibitor in human milk. (2001) (5)
- Role of Nitric Oxide in Endothelial Cell - Platelet Interactions (1991) (5)
- Increased activity of circulating polymorphonuclear leukocytes in acute myocardial infarction. (1990) (5)
- Regulation of platelet function by nitric oxide (1993) (5)
- INHALED NITRIC OXIDE (NO) INHIBITS PLATELET AGGREGATION IN CRITICALLY ILL NEONATES. † 843 (1997) (4)
- A nanoscale resolution assay of flow-induced platelet microaggregation Mikroagregacja płytek indukowana przepływem - badanie w nanorozdzielczości (2010) (4)
- Platelet microaggregation in sepsis examined by quartz crystal microbalance with dissipation technology (2018) (4)
- Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting. (2007) (4)
- Novel Barbiturate-Nitrate Compounds Inhibit the Upregulation of Matrix Metalloproteinase-9 Gene Expression in Intestinal Inflammation through a cGMP-Mediated Pathway (2020) (4)
- Increased Alveolar and Plasma Gelatinases Activity during Postpump Syndrome: Inhibition by Inhaled Nitric Oxide (2006) (4)
- Perspectives in Pharmacology Role of Matrix Metalloproteinases in Intestinal Inflammation (2006) (4)
- In vitro effects of cobalt and chromium nanoparticles on human platelet function (2020) (4)
- Inhaled nitric oxide and inhibition of platelet aggregation in critically ill (1998) (3)
- On the mechanism of angiotensin II induced release of prostacyclin. (1981) (3)
- Coronary artery aneurysm after implantation of an endothelial progenitor cell capturing stent. (2012) (3)
- FORUM EKSPERTÓW A nanoscale resolution assay of flow-induced platelet microaggregation (2011) (3)
- Nitric oxide: Implications for placental biology (1996) (3)
- Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving JNK (2006) (2)
- Platelet Regulation and Damage in Vascular Thrombotic and Septic Disorders (1995) (2)
- APOPTOTIC RESPONSE OF OVARIAN CANCER CELLS IN HYPOXIC CONDITIONS (2008) (2)
- [Matrix metalloproteinases in diseases of the gastrointestinal tract]. (2004) (2)
- Stimulatory cholinergic effect on the release of antiaggregatory activity into the circulation of cat and man and its modification by β‐adrenergic antagonists (1985) (2)
- Triple-negative Breast Cancer Cells May Transfer Phenotypic Characteristics via (2011) (2)
- Nitric oxide: Implications for placental biology: A review (1998) (2)
- NO effect on hemostasis. (1999) (2)
- Regulatory properties of vascular endothelium: focus on prostacyclin and endothelium-derived relaxing factor. (1988) (1)
- Nitric Oxide-Mediated Regulation of Platelet Function (1999) (1)
- INTEGRATED MICROFLUIDIC SYSTEMS BIOLOGY PLATFORM: CELL CULTURE, DRUG TREATMENT, LYSIS, SEPARATION, AND DETECTION (2008) (1)
- Development and pharmacological characterization of a novel plasma-based in vitro angiogenesis assay (2007) (1)
- Nitric Oxide and Platelet Function (2000) (1)
- Nanotoxicology of Nanomaterials : New Opportunities and Challenges (2016) (1)
- Nitric oxide-dependent and independent effects on human platelets treated (1998) (1)
- Angiogram of the month Optical coherence tomography-guided stent implantation (2009) (1)
- [Vascular endothelium in the processes of hemostasis and thrombosis. The role of prostacyclin and EDRF]. (1989) (1)
- Learning fiberoptic intubation on a simple model transfers to the O.R. (2001) (1)
- NANOINTERACT: A rational approach to the interaction between nanoscale materials and living matter? (2009) (1)
- Cardiac surgery and cardiology Young scientists’ migration and quality of basic science in Polish medicine (2008) (1)
- Review paper Intermediate coronary artery stenosis – when is intervention indicated and when should it be deferred? Value of intravascular ultrasound in clinical decision making in the performance of coronary interventions (2006) (1)
- The Role of Nitric Oxide in Vascular Haemostasis and Thrombosis: Implications for Septicaemia and Cell Damage (1995) (1)
- Effect of Nanoparticulate Matter on Transepithelial Ion Fluxes in Calu-3 Cells. (2009) (1)
- Matrix Metalloproteinase 2 in Tumor Cell-induced Platelet Aggregation : Regulation by Nitric Oxide 1 (2000) (0)
- vasorelaxation of rat mesenteric arteries Role of matrix metalloproteinase-2 in thrombin-induced (2011) (0)
- The effect of new aspirin prodrugs on blood platelet and tumor cells in an ‘in vitro’ study (2010) (0)
- Inner Ear Decompression Sickness in the Squirrel Monkey: Observations, Interpretations, and Mechanisms. (1983) (0)
- Platelet and leukocyte derived matrix metalloproteinases (MMP) 1, -2 in humans undergoing cardiopulmonary bypass mediate increased formation of platelet-leukocyte aggregates and platelet dysfunction (2008) (0)
- 1166 POSTER Triple-negative Breast Cancer Cells May Transfer Phenotypic Characteristics via Exosomes (2011) (0)
- Differential Inhibition of Platelet Aggregation by Indomethacin and Inhaled Nitric Oxide in Critically Ill Infants (1999) (0)
- Inhmition of matrix metalloproteinases(MMPs)prevents tissue injury and fibrotic complications in two rat models of inflammatory bowel disease (2000) (0)
- Cobalt Nanoparticles Cause Major Platelet Aggregation In Vitro While Chromium Nanoparticles Induce Platelet Lysis In Vitro. (2020) (0)
- Welcome Statement by the Chair (2009) (0)
- Atherosclerotic plaque morphology in diabetes type 2 patients (2003) (0)
- Combined administration of nitric oxide gas and prostacyclin into the oxygenator protects platelet activation and function during cardiopulmonary bypass in humans (2004) (0)
- Aluminium Nanoparticles Released by Joint Implants ‐ Quartz Crystal Microbalance with Dissipation Analysis (2020) (0)
- [Remodeling of coronary arteries examined by arteries intravascular ultrasonography]. (2003) (0)
- Title The use of quartz crystal microbalance with dissipation ( QCM-D ) for studying nanoparticle-induced platelet aggregation (2019) (0)
- Quantification of Iron Oxide Nanoparticles in a large animal model using MRI (2013) (0)
- Pharmacokinetics and biodistribution of superparamagnetic nanoparticles using pEPR in the mouse : an in vivo , in vitro and ex vivo validation (2012) (0)
- 1.P.104 The role of nitric oxide in the vasculopathy of the JCR:LA-cp rat (1997) (0)
- SUPERASPIRINS: NOVEL PRO-DRUGS ARE MORE EFFECTIVE THAN CONVENTIONAL ASPIRIN AND DO NOT CAUSE DIRECT GI TOXICITY (2011) (0)
- Pharmacological Significance of Nanoparticles (2010) (0)
- Selective PKCalpha inhibition uncouples platelet angiogenesis promotion from collagen-induced aggregation (2013) (0)
- JPET #103465 PiP 1 Title: Role of Matrix Metalloproteinases in Intestinal Inflammation Authors: (2006) (0)
- Ischaemic heart disease in patients with neoplasm (2005) (0)
- Analysis of the relationship between the inner structure and the magnitude of atherosclerotic plaques. (2003) (0)
- [Optical coherence tomography-guided stent implantation]. (2009) (0)
- The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells (2022) (0)
- NOVEL DUAL NITRIC OXIDE RELEASING ANTI-REMODELING THERAPY FOR HYPERTENSIVE HEART DISEASE (2011) (0)
- Title: PEGYLATION INCREASES PLATELET BIOCOMPATIBILITY OF GOLD NANOPARTICLES (13-518-R) (2013) (0)
- Regulación de la homeostasis vascular mediante óxido nítrico (1994) (0)
- [Cardiac revascularisation in a high-risk patient--case report]. (2004) (0)
- through a Nitric Oxide-Mediated Pathway Regulates Matrix Metalloproteinase-9 The Transcription Factor Wilms Tumor 1 (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marek Witold Radomski?
Marek Witold Radomski is affiliated with the following schools:
